Welcome to our dedicated page for Nature’S Sun SEC filings (Ticker: NATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nature’s Sunshine Products, Inc. filings document the public-company record for a Nasdaq-listed Utah corporation that manufactures and markets herbal and nutritional supplements and personal care products. Form 8-K reports furnish operating and financial results, non-GAAP reconciliations, material-event disclosures, executive appointments, compensatory arrangements, material agreements and capital-structure updates for NATR common stock.
Proxy materials cover board elections, governance practices, executive compensation, equity awards, pay-versus-performance disclosure and shareholder voting matters. The filing record also addresses risk, regulatory and business disclosures related to the company’s global wellness product operations and distribution markets.
Nature’s Sunshine Products, Inc. reported that Chief Financial Officer L. Shane Jones has resigned effective June 5, 2026, and stated that his decision was not due to any disagreement over the company’s financial reporting or accounting practices. On May 8, 2026, the company appointed longtime finance executive Jonathan D. Lanoy as Interim Principal Financial Officer. Lanoy currently serves as Senior Vice President, Chief Accounting Officer, and Principal Accounting Officer and has been with the company’s finance organization since 2008. Under an existing employment agreement, he receives an annual base salary of $301,551, a target annual bonus equal to 50 percent of base salary, and may receive 12 months of salary and health coverage continuation if his employment ends under specified conditions.
Natures Sunshine Products EVP and General Counsel Nathan G. Brower reported compensation-related share activity tied to performance milestones. On May 5, 2026, performance-based restricted stock units vested in three tranches totaling 5,775 common shares after the company achieved adjusted EBITDA milestones of $51.1M and $52M over rolling 12‑month periods. To cover tax obligations on these vestings, the company withheld a total of 1,668 common shares at a price of $25.915 per share, a tax-withholding disposition rather than an open‑market sale. After these transactions, Brower directly holds 44,359 common shares of Natures Sunshine Products.
NATURES SUNSHINE PRODUCTS INC executive Fritz Erich A reported routine equity compensation activity. On May 5, he acquired 1,372 common shares through vesting of performance-based restricted stock units tied to an adjusted EBITDA milestone of $52M over a rolling 12‑month period.
On the same date, 469 shares were withheld to cover tax obligations, based on the closing share price of $25.915. After these transactions, he directly holds 12,132 common shares, reflecting a modest net increase in ownership from this award.
Natures Sunshine Products Global Chief Marketing Officer Kevin Gregory Fuller reported routine equity compensation activity. He exercised awards tied to restricted stock units to acquire 1,677 common shares and had 573 shares withheld to cover taxes.
Following these transactions, Fuller directly holds 23,137 common shares. The vesting was triggered by the company achieving an adjusted EBITDA milestone of $52 million over a rolling 12‑month period under a performance-based restricted stock unit grant.
NATURES SUNSHINE PRODUCTS INC executive Kevin R. Herbert reported routine equity compensation activity. He acquired 1,500 common shares on May 5, 2026 through a derivative exercise related to performance-based restricted stock units tied to an adjusted EBITDA milestone of $52M over a rolling 12-month period.
On the same date, 366 common shares were withheld to cover tax obligations upon vesting, based on the closing price of $25.915 per share. Following these transactions, Herbert directly holds 42,906 common shares, reflecting net additional ownership from the award after tax withholding.
NATURES SUNSHINE PRODUCTS INC EVP & CFO Leslie Shane Jones reported compensation-related share activity in Common Shares on May 5, 2026. He exercised awards to acquire 2,484 shares in one transaction and 4,004 shares in another, and had 1,090 and 1,756 shares withheld to cover taxes at $25.915 per share. The vested shares resulted from achieving adjusted EBITDA milestones of $51.1M and $52M under performance-based restricted stock unit grants. After these transactions, he directly held 103,264 common shares. These were tax and award-related entries, not open-market trades.
NATURES SUNSHINE PRODUCTS INC senior vice president and chief accounting officer Jonathan David Lanoy reported routine equity compensation activity in common shares. Performance-based restricted stock units vested after the company achieved adjusted EBITDA milestones of $51.1M and $52M over rolling 12‑month periods. To cover related tax obligations, 912 shares of NATR common stock were withheld at $25.915 per share. Following these vesting and tax-withholding transactions, Lanoy directly holds 40,366 common shares.
Natures Sunshine Products EVP & President, Asia Daniel C. Norman reported compensation-related share activity. On May 5, 2026, performance-based restricted stock units vested after the company achieved adjusted EBITDA milestones of $51.1M and $52M over rolling 12‑month periods. These vestings resulted in multiple grants converting into common shares for the executive.
To cover associated tax liabilities upon vesting, a total of 2,104 common shares were withheld at a price of $25.915 per share, recorded as tax-withholding dispositions rather than open-market sales. Following these transactions, Norman directly holds 42,169 common shares of NATR.
Natures Sunshine Products Chief Executive Officer Kenneth G. Romanzi reported equity compensation activity tied to performance-based restricted stock units. After the company achieved an adjusted EBITDA milestone of $52M over a rolling 12-month period, 13,118 common shares vested for him.
To cover related tax obligations upon vesting, 5,753 common shares were withheld at a value of $25.915 per share, rather than sold in the open market. Following these compensation and tax-withholding movements, Romanzi directly holds 110,246 common shares of NATR.
Natures Sunshine Products EVP & President, Europe, Bryant J. Yates reported routine equity compensation activity. On May 5, 2026, he exercised performance-based awards to acquire a total of 6,798 Common Shares and had 1,963 shares withheld to cover tax obligations.
The awards vested after the company achieved adjusted EBITDA milestones of $51.1M and $52M over rolling 12-month periods under performance-based restricted stock unit grants made in 2022, 2023, and 2025. The tax-withholding dispositions were priced at $25.915 per share and were not open-market sales.